FDA Citizen Petition Proposal Inhibits OTC Drug Review Process - CTFA
This article was originally published in The Rose Sheet
Executive Summary
An FDA proposal to ban citizen petitions on pending regulations "appears to preclude the introduction of new data and information in the OTC drug review," the Cosmetic, Toiletry and Fragrance Association argues in Feb. 28 comments.